Literature DB >> 16112258

Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain.

Chengru Zhu1, Shuzhang Feng, Timothy E Thate, James B Kaper, Edgar C Boedeker.   

Abstract

The ler (LEE encoded regulator) gene product is a central regulator for the genes encoded on the locus of enterocyte effacement (LEE) pathogenicity island of attaching/effacing (A/E) pathogens, including human enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli (EHEC) as well as animal isolates. Although an in vivo role for Ler in bacterial virulence has not been documented, we hypothesized that a Ler deletion mutant should be attenuated for virulence but might retain immunogenicity. The goals of this study were to genetically characterize ler of a rabbit EPEC (rEPEC) strain (O103:H2), to examine the effect of ler on in vivo virulence, and to determine if intragastric inoculation of an attenuated rEPEC ler mutant was immunogenic and could protect rabbits against subsequent challenge with the wild-type virulent parent strain. The predicted ler gene product of rEPEC strain O103:H2 shares high homology (over 95% amino acid identity) with the Lers of another rEPEC strain RDEC-1 (O15:H-) and human EPEC and EHEC. A defined internal ler deletion mutant of rEPEC O103:H2 showed reduced production of secreted proteins. Although orogastric inoculation of rabbits with the virulent parent O103:H2 strain induced severe diarrhea, significant weight loss and early mortality with adherent mucosal bacteria found at sacrifice, the isogeneic ler mutant strain was well tolerated. Animals gained weight and showed no clinical signs of disease. Examination of histological sections of intestinal segments revealed the absence of mucosal bacterial adherence. This result demonstrates an essential role for Ler in in vivo pathogenicity of A/E E. coli. Single dose orogastric immunization with the rEPEC ler mutant induced serum IgG antibody to whole bacteria (but not to intimin). Immunized animals were protected against enteric infection with the WT virulent parent strain exhibiting normal weight gain, absence of diarrhea and absence of mucosally adherent bacteria at sacrifice. Such attenuated ler mutant strains may have potential for use as oral vaccines, or as vaccine vectors for delivery of foreign antigens. It remains to be determined whether such regulatory mutants can protect against infection with A/E bacteria of differing serotypes affecting different hosts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112258     DOI: 10.1016/j.vaccine.2005.07.019

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  QseA directly activates transcription of LEE1 in enterohemorrhagic Escherichia coli.

Authors:  Faith C Sharp; Vanessa Sperandio
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

Review 2.  Enteropathogenic and enterohemorrhagic Escherichia coli virulence gene regulation.

Authors:  Jay L Mellies; Alex M S Barron; Anna M Carmona
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

3.  Quantitation of rabbit cytokine mRNA by real-time RT-PCR.

Authors:  Charmie Godornes; Brandon Troy Leader; Barbara J Molini; Arturo Centurion-Lara; Sheila A Lukehart
Journal:  Cytokine       Date:  2007-05-22       Impact factor: 3.861

4.  Control of bacterial virulence by the RalR regulator of the rabbit-specific enteropathogenic Escherichia coli strain E22.

Authors:  Yogitha N Srikhanta; Dianna M Hocking; Matthew J Wakefield; Ellen Higginson; Roy M Robins-Browne; Ji Yang; Marija Tauschek
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

5.  The type II secretion system and its ubiquitous lipoprotein substrate, SslE, are required for biofilm formation and virulence of enteropathogenic Escherichia coli.

Authors:  Deborah L Baldi; Ellen E Higginson; Dianna M Hocking; Judyta Praszkier; Rosalia Cavaliere; Catherine E James; Vicki Bennett-Wood; Kristy I Azzopardi; Lynne Turnbull; Trevor Lithgow; Roy M Robins-Browne; Cynthia B Whitchurch; Marija Tauschek
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

Review 6.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

7.  RegR virulence regulon of rabbit-specific enteropathogenic Escherichia coli strain E22.

Authors:  Yogitha N Srikhanta; Dianna M Hocking; Judyta Praszkier; Matthew J Wakefield; Roy M Robins-Browne; Ji Yang; Marija Tauschek
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

8.  Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector.

Authors:  Rogeria Keller; Tamara D Hilton; Hernam Rios; Edgar C Boedeker; James B Kaper
Journal:  Microb Pathog       Date:  2009-10-28       Impact factor: 3.738

9.  Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium.

Authors:  Víctor A García-Angulo; Wanyin Deng; Nikhil A Thomas; B Brett Finlay; Jose L Puente
Journal:  J Bacteriol       Date:  2008-01-25       Impact factor: 3.490

10.  The possible influence of LuxS in the in vivo virulence of rabbit enteropathogenic Escherichia coli.

Authors:  Chengru Zhu; Shuzhang Feng; Venessa Sperandio; Zhuolu Yang; Timothy E Thate; James B Kaper; Edgar C Boedeker
Journal:  Vet Microbiol       Date:  2007-06-15       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.